Engineered cell instructive matrices for fetal membrane healing
Source abstract
Abstract
Iatrogenic preterm prelabour rupture of fetal membranes (iPPROM) occurs in 6-45% of the cases after fetoscopic procedures, posing a significant threat to fetal survival and well-being. The number of diagnostic and therapeutic prenatal interventions available is increasing, thus developing treatment options for iPPROM is becoming more important than ever before. Fetal membranes exhibit very restricted regeneration and little is known about factors which might modulate their healing potential, rendering various materials and strategies to seal or heal fetal membranes pursued over the past decades relatively fruitless. Additionally, biocompatible materials with tunable in vivo stability and mechanical and biological properties have not been available. Using poly(ethylene glycol)-based biomimetic matrices, we provide evidence that, upon presentation of appropriate biological cues in three dimensions, mesenchymal progenitor cells from the amnion can be mobilized, induced to proliferate and supported in maintaining their native extracellular matrix production, thus creating a suitable environment for healing to take place. These data suggest that engineering materials with defined mechanical and biochemical properties and the ability to present migration- and proliferation-inducing factors, such as platelet-derived growth factor, basic fibroblast growth factor or epidermal growth factor, could be key in resolving the clinical problem of iPPROM and allowing the field of fetal surgery to move forward.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Preterm Birth and Chorioamnionitis · Congenital Anomalies and Fetal Surgery · Tissue Engineering and Regenerative Medicine
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (59)
Show source-provided references
1. Preterm prelabor rupture of membranes and fetal survival after minimally invasive fetal surgery: a systematic review of the literature10.1159/000331165 ↗
2. Outcomes of children of extremely low birthweight and gestational age in the 1990’s10.1016/S0378-3782(98)00052-8 ↗
3. Fetal surgery is a clinical reality10.1016/j.siny.2009.10.002 ↗
4. Benirschke · 2012 · 249
5. Epidermal cytokines and their roles in cutaneous wound healing10.1111/j.1365-2133.1991.tb04942.x ↗
6. A histological study of fetoscopic membrane defects to document membrane healing10.1016/j.placenta.2005.03.008 ↗
7. Matrix metalloproteinases-2 and -9 and their endogenous tissue inhibitors in fetal membrane repair following fetoscopy in a rabbit model10.1093/molehr/6.5.479 ↗
8. Fetoscopic closure of punctured fetal membranes with acellular human amnion plugs in a rabbit model10.1097/01.AOG.0000284624.23598.7c ↗
9. Enhancing sealing of fetal membrane defects using tissue engineered native amniotic scaffolds in the rabbit model10.1016/j.ajog.2006.10.904 ↗
10. Increased polymorphonuclear infiltration and iatrogenic amniotic band after closure of fetoscopic access sites with a bioactive membrane in the rabbit at midgestation10.1067/mob.2003.213 ↗
11. Fetal membrane closure techniques after hysteroamniotomy in the midgestational rabbit model10.1016/S0002-9378(98)70527-7 ↗
12. Gelatin sponge plug to seal fetoscopy port sites: technique in ovine and primate models10.1016/S0002-9378(99)70338-8 ↗
13. Successful sealing of fetoscopic access sites with collagen plugs in the rabbit model10.1016/S0002-9378(00)70503-5 ↗
14. The closure of iatrogenic membrane defects after amniocentesis and endoscopic intrauterine procedures10.1159/000076715 ↗
15. Closure techniques for fetoscopic access sites in the rabbit at mid-gestation10.1093/humrep/14.7.1730 ↗
16. Fetal membrane healing after spontaneous and iatrogenic membrane rupture: a review of current evidence10.1016/j.ajog.2006.01.074 ↗
17. Efficacy of fibrin glue for in vitro sealing of human chorioamniotic membranes
18. Comparative characterization of cultured human term amnion epithelial and mesenchymal stromal cells for application in cell therapy10.3727/096368908786576507 ↗
19. Ex vivo characteristics of human amniotic membrane derived stem cells10.1089/clo.2007.0027 ↗
20. Dose-dependent immunomodulatory effect of human stem cells from amniotic membrane: a comparison with human mesenchymal stem cells from adipose tissue10.1089/ten.2006.0313 ↗
21. Biomolecular hydrogels formed and degraded via site-specific enzymatic reactions10.1021/bm070228f ↗
22. Enzymatic formation of modular cell-instructive fibrin analogs for tissue engineering10.1016/j.biomaterials.2007.03.027 ↗
23. Elucidating the role of matrix stiffness in 3D cell migration and remodeling10.1016/j.bpj.2010.11.082 ↗
24. A versatile approach to engineering biomolecule-presenting cellular microenvironments10.1002/adhm.201200280 ↗
25. The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities10.1634/stemcells.2007-0054 ↗
26. Signaling pathways involved in migration of mesenchymal stem cells
27. Adult and umbilical cord blood-derived platelet-rich plasma for mesenchymal stem cell proliferation, chemotaxis, and cryo-preservation10.1016/j.biomaterials.2012.04.007 ↗
28. Delivery of platelet-derived growth factor as a chemotactic factor for mesenchymal stem cells by bone-mimetic electrospun scaffolds10.1371/journal.pone.0040831 ↗
29. IGF-I and IGF-II stimulate directed cell migration of bone-marrow-derived human mesenchymal progenitor cells10.1016/j.bbrc.2006.05.034 ↗
30. Rasband WS. ImageJ, U.S. National Institutes of Health, Bethesda, MD, . 1997–2012.
31. Feature point tracking and trajectory analysis for video imaging in cell biology10.1016/j.jsb.2005.06.002 ↗
32. Plasticity of cell migration: a multiscale tuning model10.1083/jcb.200909003 ↗
33. In vitro study of matrix metalloproteinase/tissue inhibitor of metalloproteinase production by mesenchymal stromal cells in response to inflammatory cytokines: the role of their migration in injured tissues10.1080/14653240903051541 ↗
34. Matrix metalloproteinase 1 is necessary for the migration of human bone marrow-derived mesenchymal stem cells toward human glioma10.1002/stem.50 ↗
35. Building epithelial architecture: insights from three-dimensional culture models10.1038/nrm859 ↗
36. Random versus directionally persistent cell migration10.1038/nrm2729 ↗
37. Dimensions in cell migration10.1016/j.ceb.2013.06.004 ↗
38. Extracellular matrix dynamics in development and regenerative medicine10.1242/jcs.006064 ↗
39. On the origin of amniotic stem cells: of mice and men10.1387/ijdb.092935md ↗
40. Establishment and characterization of a pluripotent stem cell line derived from human amniotic membranes and initiation of germ layers in vitro10.1111/j.1749-0774.2004.tb00028.x ↗
41. Term amnion is a high throughput source for multipotent mesenchymal stem cells with the ability to differentiate to endothelial cells in vitro10.1186/1471-213X-7-11 ↗
42. In vitro lesion repair by human amnion epithelial and mesenchymal cells10.1016/j.ajog.2003.07.011 ↗
43. Repair kinetics of amnion cells after microsurgical injury10.1159/000264340 ↗
44. Growth factors in fetal membrane healing: evaluation using confluent cultures of amnion derived epithelial WISH cells
45. Inducing proliferation of human amnion epithelial and mesenchymal cells for prospective engineering of membrane repair
46. Tissue engineering a fetal membrane10.1089/ten.tea.2011.0194 ↗
47. Human preterm amnion cells cultured in 3-dimensional collagen I and fibrin matrices for tissue engineering purposes10.1016/j.ajog.2005.04.005 ↗
48. Premature rupture of the fetal membranes: is the amnion the major determinant?10.1016/j.ajog.2006.02.010 ↗
49. Generic strategy for pharmacological caging of growth factors for tissue engineering10.1039/c3cc41616j ↗
50. Chemotaxis of human articular chondrocytes and mesenchymal stem cells10.1002/jor.20668 ↗
51. C-Jun N-terminal kinase is necessary for platelet-derived growth factor-mediated chemotaxis in primary fibroblasts10.1074/jbc.M513307200 ↗
52. Retention of multilineage differentiation potential of mesenchymal cells during proliferation in response to FGF10.1006/bbrc.2001.5777 ↗
53. Tethered epidermal growth factor provides a survival advantage to mesenchymal stem cells10.1634/stemcells.2006-0320 ↗
54. Controlling mesenchymal stem cell differentiation by TGFβ family members10.1007/s00776-003-0702-2 ↗
55. The extracellular matrix of the human fetal membranes: structure and function10.1016/S0143-4004(98)90092-3 ↗
56. Interstitial collagen synthesis and processing in human amnion: a property of the mesenchymal cells10.1095/biolreprod55.6.1253 ↗
57. Manufacture of a cell-free amnion matrix scaffold that supports amnion cell outgrowth in vitro10.1016/j.placenta.2006.01.004 ↗
58. Mechanical induction of gene expression in connective tissue cells10.1016/S0091-679X(10)98008-4 ↗
59. CTGF directs fibroblast differentiation from human mesenchymal stem/stromal cells and defines connective tissue healing in a rodent injury model10.1172/JCI43230 ↗